Anterix stock climbs to all-time high as year-to-date gains near 400%
at seekingalpha.com (Mon, 20-Jul 10:31 AM)
Analyst Sees Material Upside for AN2 Therapeutics as Epetraborole Targets Underserved Polycythemia Vera Market
at www.tipranks.com (Mon, 20-Jul 5:25 AM)
